Ameritas Investment Partners Inc. raised its holdings in shares of Masimo Corporation (NASDAQ:MASI) by 4.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,559 shares of the medical equipment provider’s stock after buying an additional 802 shares during the period. Ameritas Investment Partners Inc.’s holdings in Masimo Corporation were worth $1,601,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. BlackRock Inc. boosted its holdings in Masimo Corporation by 7.5% during the second quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock worth $721,710,000 after buying an additional 550,995 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Masimo Corporation by 6.9% during the second quarter. Vanguard Group Inc. now owns 4,935,693 shares of the medical equipment provider’s stock worth $450,036,000 after buying an additional 318,060 shares in the last quarter. Acadian Asset Management LLC boosted its holdings in Masimo Corporation by 28.0% during the second quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock worth $163,356,000 after buying an additional 392,410 shares in the last quarter. State Street Corp boosted its holdings in Masimo Corporation by 10.4% during the second quarter. State Street Corp now owns 1,547,728 shares of the medical equipment provider’s stock worth $141,121,000 after buying an additional 146,212 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in Masimo Corporation by 3.6% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,113,113 shares of the medical equipment provider’s stock worth $101,494,000 after buying an additional 38,991 shares in the last quarter. Hedge funds and other institutional investors own 83.21% of the company’s stock.

A number of brokerages recently weighed in on MASI. Roth Capital raised their target price on shares of Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. BidaskClub cut shares of Masimo Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Zacks Investment Research upgraded shares of Masimo Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, July 11th. Stifel Nicolaus began coverage on shares of Masimo Corporation in a report on Monday, July 10th. They set a “buy” rating and a $105.00 target price for the company. Finally, BTIG Research upgraded shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $97.00.

In related news, Director Sanford Fitch sold 11,000 shares of the business’s stock in a transaction that occurred on Thursday, August 17th. The shares were sold at an average price of $87.25, for a total transaction of $959,750.00. Following the completion of the sale, the director now directly owns 72,249 shares of the company’s stock, valued at $6,303,725.25. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Jon Coleman sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, July 20th. The stock was sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the sale, the insider now directly owns 32,201 shares of the company’s stock, valued at $3,139,597.50. The disclosure for this sale can be found here. Insiders own 16.60% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/10/15/ameritas-investment-partners-inc-raises-position-in-masimo-corporation-masi.html.

Masimo Corporation (MASI) traded down 0.58% during trading on Friday, reaching $85.01. 216,288 shares of the company were exchanged. The firm has a market cap of $4.42 billion, a price-to-earnings ratio of 13.93 and a beta of 0.82. Masimo Corporation has a 52-week low of $53.78 and a 52-week high of $104.71. The firm has a 50-day moving average of $85.41 and a 200-day moving average of $89.89.

Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.12. The business had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. Masimo Corporation’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.57 earnings per share. On average, equities analysts forecast that Masimo Corporation will post $2.80 EPS for the current year.

Masimo Corporation Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.